Understanding Glaucoma Medications (cont.)
Medical Author:
Andrew A. Dahl, MD, FACS
Andrew A. Dahl, MD, FACSAndrew A. Dahl, MD, is a board-certified ophthalmologist. Dr. Dahl's educational background includes a BA with Honors and Distinction from Wesleyan University, Middletown, CT, and an MD from Cornell University, where he was selected for Alpha Omega Alpha, the national medical honor society. He had an internal medical internship at the New York Hospital/Cornell Medical Center. Medical Editor:
William C. Shiel Jr., MD, FACP, FACR
William C. Shiel Jr., MD, FACP, FACRDr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology. IN THIS ARTICLE
HyperosmoticsHyperosmotics are sugar-based liquids meant to be taken by mouth. Hyperosmotics are used in the treatment of rapid-onset angle-closure glaucoma. The effects last only 6 to 8 hours, so they are not for long-term use. Hyperosmotics include mannitol (Osmitrol), glycerin (Osmoglyn), and isosorbide (Ismotic). Who should not use these medications:
Use: These drugs are given orally or by injection to rapidly correct high elevations of intraocular pressure. Drug or food interactions: Hyperosmotics may decrease lithium levels. Side effects: Hyperosmotics should be used with caution in people who have diseases worsened by salt retention. Many patients with glaucoma require more than one type of medication for adequate control of their glaucoma. Combined medications can offer an alternative for patients who need more than one type of medication. In addition to the convenience of using one eye drop bottle instead of two, there may also be a financial advantage, depending on the insurance plan. Cosopt is a combination of a beta blocker (timolol) and a carbonic anhydrase inhibitor (Trusopt). Combigan combines an alpha agonist (brimonidine) with a beta blocker (timolol). Combinations of prostaglandin analogs and beta adrenergic blockers are available in Europe and are awaiting FDA approval in the United States. Next Page: Must Read Articles Related to Understanding Glaucoma Medications
Adult Glaucoma Suspect
Glaucoma is usually high pressure inside the eye that damages the optic nerve and can result in permanent vision loss. Not all 3 criteria (that is, high pressur...learn more >>
Allergic Reaction
An allergic reaction is an overreaction to a harmless substance. Symptoms and signs of an allergic reaction include hives, rashes, swelling, itching, wheezing, ...learn more >>
Angle Recession Glaucoma
Traumatic glaucoma refers to a group of ocular disorders that occur after the eye undergoes trauma. Following this trauma, different mechanisms can cause an abn...learn more >>
Viewer Comments & ReviewsGlaucoma Medications - Side EffectsThe eMedicineHealth physician editors ask:Do you experience troubling side effects from your glaucoma medication? |
WebMD Daily
Get breaking medical news.
From WebMD
Eye Health Resources
Featured Centers
Health Solutions From Our Sponsors
Read What Your Physician is Reading on Medscape
Glaucoma, Unilateral: Treatment & Medication »
While any type of glaucoma can be unilateral, primary open-angle glaucoma, primary angle-closure glaucoma, primary infantile glaucoma, juvenile-onset glaucoma, and pigmentary glaucoma are generally bilateral diseases, the severity of which may be asymmetric in the two eyes.
Featured Topics
Medical Dictionary
Pill Identifier on RxList
- quick, easy,
pill identification
Find a Local Pharmacy
- including 24 hour, pharmacies




